Hoth Therapeutics (NASDAQ: HOTH) Stock Skyrockets Following Approval of HT-001 Phase 2a Human Trials
Hoth Therapeutics (NASDAQ: HOTH) stock surged over 80% during intraday trading after securing approval for the first-in-human Phase 2a clinical […]
HOTH
Hoth Therapeutics, Inc. (HOTH) Shares Skyrocket on Tuesday. Here’s Why
Shares of Hoth Therapeutics, Inc. (NASDAQ: HOTH) skyrockets 78.19% to $3.35. The exhilarating rally follows the company’s revelation of extraordinary preclinical
Hoth Therapeutics, Inc. (HOTH) Shares Skyrocket on Tuesday. Here’s Why Read More »